Panbela Therapeutics, Inc.

CIK 1029125 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Panbela Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 29, 2025SEC STAFF ACTION9999999997-25-003686
Apr 24, 2025SCHEDULE 13D/A0000950170-25-058254
Feb 18, 20258-K0001437749-25-004225
Feb 4, 20258-K0001437749-25-002718
Jan 22, 20258-K0001437749-25-001557
Jan 10, 2025S-80001437749-25-000865
Nov 19, 202440000950170-24-128924
Nov 18, 2024424B30001437749-24-035635
Nov 18, 2024424B30001437749-24-035634
Nov 18, 20248-K0001437749-24-035616
Nov 18, 2024424B30001437749-24-035640
Nov 18, 2024424B30001437749-24-035639
Nov 18, 2024424B30001437749-24-035641
Nov 18, 2024424B30001437749-24-035636
Nov 18, 2024424B30001437749-24-035643
Nov 15, 2024424B30001437749-24-035415
Nov 15, 2024424B30001437749-24-035410
Nov 15, 2024424B30001437749-24-035411
Nov 15, 2024424B30001437749-24-035414
Nov 15, 2024424B30001437749-24-035416
Nov 15, 2024424B30001437749-24-035413
Nov 15, 2024424B30001437749-24-035412
Nov 14, 20248-K0001437749-24-035305
Nov 14, 202410-Q0001437749-24-035315
Oct 29, 2024424B30001437749-24-032394